Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer

Ziyan Yang, Wen‐Ming Cao|npj Breast Cancer|2023

Cited by 8